GSK
Live / Registered — Registered (as of 22 Sept 2026)
What this means for you
Registered since 22 Sept 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 22 Sept 2032: the §8 declaration of use).
Record
- Serial number
- 97446071
- Registration number
- 8451018
- Mark type
- Design + words
- Filed
- 07 Jun 2022
- Published for opposition
- 01 Aug 2023
- Registered
- 22 Sept 2026
- Next maintenance filing
- §8 declaration of use, due by 22 Sept 2032 (grace period to 22 Mar 2033)
- Attorney of record
- Christopher M. Hanes
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation; Pharmaceutical preparations for the treatment of viral, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, psychiatric and immune system related diseases and disorders; vaccines; adjuvants for medical purposes.
- Class 042 — Scientific and technological services: Scientific research for medical purposes in the field of pharmaceuticals, vaccines; research and development services in the fields of bioelectronics, drug discovery, drug discovery products, pharmaceuticals, medicinal diagnostics, biochemicals, biotechnology, biological products, medical apparatus, devices and instruments; scientific research consulting; medical laboratory services; Providing medical and scientific research information; medical and pharmacological research services; software development, programming and implementation; provision of information, consultancy and advisory services relating to any of the aforesaid services
- Class 044 — Medical, beauty and agricultural services: Medical and healthcare services; provision of medical information and medical services; information provided to patients and healthcare professionals concerning pharmaceutical products, vaccines, medical diseases and disorders and related treatments; provision of information, consultancy and advisory services relating to any of the aforesaid services
Owner
- SmithKline Beecham Limited, London, GB
- SmithKline Beecham Limited, London, GB
- SmithKline Beecham Limited, Brentford, Middlesex, GB
Board proceedings on this mark
- Extension of Time to Oppose No. 97446071 — Vericel Corporation v. SmithKline Beecham Limited, filed 18 Aug 2023 (Terminated)
Prosecution history
- 22 Sept 2026 — REGISTERED-PRINCIPAL REGISTER
- 03 Sept 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 03 Sept 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 25 Aug 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 13 Jul 2026 — USE AMENDMENT FILED
- 13 Jul 2026 — TEAS STATEMENT OF USE RECEIVED
- 07 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Mar 2026 — SOU EXTENSION 4 GRANTED
- 06 Mar 2026 — SOU EXTENSION 4 FILED
- 06 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 11 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Sept 2025 — SOU EXTENSION 3 GRANTED
- 10 Sept 2025 — SOU EXTENSION 3 FILED
- 10 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 13 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED